Decentralized Science (DeSci) is becoming a crucial aspect of Web3 development, as it solves fundamental problems such as unequal research funding, intellectual property monopolies, and lack of transparency in scientific research. By leveraging DAO, IP-NFTs, and token economies, DeSci empowers scientific innovation, drives the real-world adoption of Web3, and accelerates progress toward fairer and more open research.
This report conducts a detailed backtest comparing the investment performance of Dollar-Cost Averaging (DCA) versus Buy-and-Hold strategies for BTC, ETH, SOL, GT, and their combinations in Gate.io investment products from September 1, 2021, to December 30, 2024. The report uses an example-based approach to demonstrate the calculation steps and core formulas for each strategy, accompanied by data tables for key periods.
DeSci (Decentralized Science) is becoming a hot topic in the blockchain industry, sparking widespread discussion, especially in the field of innovative drug funding. However, there is a significant mismatch between DeSci and the biopharmaceutical industry in terms of funding, timelines, and operational models, making integration highly challenging. This article provides an in-depth analysis of the current state, challenges, and potential development paths of DeSci in the innovative drug sector, including new models such as IP-NFTs, RWAs, and clinical data prediction.
Decentralized Science (DeSci) is becoming a crucial aspect of Web3 development, as it solves fundamental problems such as unequal research funding, intellectual property monopolies, and lack of transparency in scientific research. By leveraging DAO, IP-NFTs, and token economies, DeSci empowers scientific innovation, drives the real-world adoption of Web3, and accelerates progress toward fairer and more open research.
This report conducts a detailed backtest comparing the investment performance of Dollar-Cost Averaging (DCA) versus Buy-and-Hold strategies for BTC, ETH, SOL, GT, and their combinations in Gate.io investment products from September 1, 2021, to December 30, 2024. The report uses an example-based approach to demonstrate the calculation steps and core formulas for each strategy, accompanied by data tables for key periods.
DeSci (Decentralized Science) is becoming a hot topic in the blockchain industry, sparking widespread discussion, especially in the field of innovative drug funding. However, there is a significant mismatch between DeSci and the biopharmaceutical industry in terms of funding, timelines, and operational models, making integration highly challenging. This article provides an in-depth analysis of the current state, challenges, and potential development paths of DeSci in the innovative drug sector, including new models such as IP-NFTs, RWAs, and clinical data prediction.